Ribomic (TSE:4591) ROE % Adjusted to Book Value: -24.73% (As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
30 GF Score
Price 円59.00
! 3 Warning Signs
View Full Analysis

What is Ribomic ROE % Adjusted to Book Value?

Ribomic TSE:4591 +1.72% 30 ROE % Adjusted to Book Value is -24.73% as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Ribomic's ROE % for the quarter that ended in Mar. 2026 was -41.54%. Ribomic's PB Ratio for the quarter that ended in Mar. 2026 was 1.68. Ribomic's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -24.73%.

Ribomic ROE % Adjusted to Book Value Related Terms

Ribomic ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Ribomic's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic ROE % Adjusted to Book Value Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.61 -23.80 -26.61 -21.99 -23.17

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.26 -28.75 -23.65 -21.69 -24.73

TSE:4591 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Ribomic's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ribomic ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ribomic's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ribomic's ROE % Adjusted to Book Value falls into.


TSE:4591
30GF Score
Ribomic Inc TSE:4591
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic ROE % Adjusted to Book Value Calculation

Ribomic's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-38.93% / 1.68
=-23.17%

Ribomic's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-41.54% / 1.68
=-24.73%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -24.73% mean?
Ribomic (TSE:4591) has a ROE % Adjusted to Book Value of -24.73% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ribomic and its competitors.
Is Ribomic's ROE % Adjusted to Book Value too high?
Ribomic's current ROE % Adjusted to Book Value is -24.73%. Overall, Ribomic has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's ROE % Adjusted to Book Value compare to VRTX and REGN?
Ribomic's ROE % Adjusted to Book Value of -24.73% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ribomic and its competitors. Ribomic's current ROE % Adjusted to Book Value is -24.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current ROE % Adjusted to Book Value of -24.73%. The current ROE % Adjusted to Book Value is -24.73%. Ribomic's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Ribomic (TSE:4591), the current ROE % Adjusted to Book Value is -24.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
30GF Score

Get the complete analysis for TSE:4591

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円59.00
Price